Pàgina d'iniciABUS • NASDAQ
add
Arbutus Biopharma Corp
Tancament anterior
4,26 $
Interval de preus d'avui
4,24 $ - 4,34 $
Interval anual
2,71 $ - 5,10 $
Capitalit. borsària
821,22 M USD
Volum mitjà
2,67 M
Ràtio preu-benefici
-
Rendibilitat per dividend
-
Borsa principal
NASDAQ
Notícies dels mercats
Informació
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Conseller delegat, CO
Data de fundació
2007
Lloc web
Empleats
44
